- Home
- / Chi Sheng Pharma & Biotech
Chi Sheng Pharma & Biotech
Stock Price
NT$26.3
2024-10-29
Market Capitalization
NT$1.5 B
2024-10-29
Revenue
NT$1.4 B
FY, 2025
Chi Sheng Pharma & Biotech Summary
Company Summary
- Overview
- Chi Sheng Pharma & Biotech (濟生醫藥生技股份有限公司) is a manufacturer and distributor of medical medicines and equipment. It offers amino acid and vitamin injections, antibiotics, cough syrups, healthcare foods, infusion sets, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1962
- Website
- http://www.cscp.com.tw
- Cybersecurity rating
Table of Contents
Chi Sheng Pharma & Biotech Financials
Summary Financials
- Revenue (FY, 2025)
- NT$1.4B
- Gross profit (FY, 2025)
- NT$595.2M
- Net income (FY, 2025)
- NT$164.3M
- Cash (FY, 2025)
- NT$443.9M
- EBIT (FY, 2025)
- NT$200.5M
- Enterprise value
- $1.1B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026